Close

content

TraceLink Announces Results from FDA DSCSA Pilot Program

TraceLink Inc., the leading digital platform company for the life science supply chain, today announced results from its pilot for the Food and Drug...

GigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant Hyperimmune Drug for COVID-19, GIGA-2050

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced the company has initiated large-scale...

Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO in Newly Diagnosed Multiple Myeloma

Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLAROâ„¢ (ixazomib) to lenalidomide and dexamethasone versus lenalidomide...

iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201

iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has selected IBIO-201, its LicKMâ„¢-ubunit vaccine, as its leading candidate for...

Tjoapack invests in automated injectables packaging capabilities

Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials. The automated packaging line for vials will...

Hear this! Potential therapeutics for COVID-19 should be tested for auditory safety

As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find treatments to...

Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists

Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read